Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2026-02-02 @ 3:53 AM
Study NCT ID:
NCT06485466
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-06-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma
Sponsor:
Organization: